Thalidomide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01041 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 8 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | ganglioneuroblastoma (disease) | KG + DL |
| 2 | vertebral anomalies and variable endocrine and T-cell dysfunction | KG + DL |
| 3 | retroperitoneal neoplasm | KG + DL |
| 4 | neuroblastoma | KG + DL |
| 5 | brachydactyly-syndactyly syndrome | KG + DL |
| 6 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 7 | rheumatoid arthritis | KG + DL |
| 8 | myeloid leukemia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.